Utilizing mTOR Inhibitors to Stabilize Intermediate Filaments in Epidermolysis Bullosa
Time: 12:00 pm
day: Day Two Clinical Track AM
Details:
- Examining the role of mechanistic target of rapamycin (mTOR) in Epidermolysis Bullosa to unveil the rationale behind mTOR inhibition
- Exploring mTOR inhibitor’s ability to degrade and remove mutant keratins through stimulation of autophagy
- The promise of BM-3103 in orphan diseases as a novel approach to treating unmet needs
